子类别 報告 [0/1] 專利 [0/11] 期刊論文 [193/194] 會議論文/會議摘要 [41/48] 邻近社群 于重元 [19/19] 劉柯俊 [85/98] 劉滄梧 [119/125] 劉界元(2003-2010) [3/3] 夏和雄(1996-2012) [26/31] 夏興國 [51/54] 姜乃榕 [82/94] 常慧如 [39/44] 張光裕 [69/79] 張憶壽 [104/107] 張文祥 [52/53] 張書銘 [89/91] 彭汪嘉康(1996-2007) [120/126] 施能耀 [37/43] 李家惠 [29/29] 李岳倫 [48/49] 林素芳 [32/32] 楊奕馨 [41/42] 江士昇 [88/90] 沈哲宏 [14/16] 洪文俊 [88/88] 莊雙恩 [82/91] 蔡坤志 [32/34] 蔡慧珍 [67/72] 蘇勇曄 [40/40] 蘇振良 [24/25] 郭靜娟 [71/76] 陳尚鴻 [45/48] 陳振陽 [72/72] 陳立宗 [444/511] 陳美霞(2002-2009) [1/1] 陳詩政 [2/2] 陳雅雯 [38/39] 黃智興 [55/55] 黃道揚 [26/26] 丁兆治(2000-2004) [5/5] 其他 [465/472] 劉敏(1996-2007) [60/62] 劉玫英(2004-2006) [2/2] 吳成文(1996-2008) [53/55] 曾思文(1997-2007) [4/4] 李冠德(1997-2004) [4/6] 林景太(1999-2007) [5/5] 楊文光(1996-1999) [21/21] 王全正(1996-2003) [4/4] 莊聲宏(1997-2004) [11/11] 詹宗晃(2000-2008) [2/2] 賴基銘(2004-2008) [41/47] 阮麗蓉(2000-2006) [6/7] 陳俊叡(2003-2007) [6/6] 馬彥英(1997-1999) [1/1] 黃奇英(2005-2007) [9/10] 社群统计 近3年内发表的文件:0(0.00%) 含全文笔数:234(92.13%) 文件下载次数统计 下载大于0次:234(100.00%) 下载大于100次:234(100.00%) 全文下载总次数:147187(2.75%) 最后更新时间: 2024-12-03 09:09 上传排行 数据加载中..... 下载排行 数据加载中..... 最近上传 Identification of prognostic biomar... A novel NRF2/ARE inhibitor gossypol... Targeting lysosomal cysteine protea... c-MYC-directed NRF2 drives malignan... Ephrin A4-ephrin receptor A10 signa... Phase I dose-escalation study of SC... Germline susceptibility variants im... Index of cancer-associated fibrobla... The SMAC mimetic LCL161 is a direct... The tumor suppressor TGFBR3 blocks ...

跳至: (选择年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (选择月份) January February March April May June July August September October November December 或输入年份:

由新到旧排序 由最旧的开始

显示项目151-175 / 254. (共11页) << < 2 3 4 5 6 7 8 9 10 11 > >> 每页显示[10|25|50]项目

日期	题名	關聯
2011-04	Activation of NRF2/ABCC1 axis confers resistance to topoisomerase II poisons in human oral malignancies	Cancer Research. 2011 Apr;71:Abstract number 1528.
2011-04	MPT0B098, a novel microtubule inhibitor, displays potent anti-angiogenic activity via destabilizing hypoxia-inducible factor-1alpha mRNA	Cancer Research. 2011 Apr;71(Suppl. 8):Meeting Abstract 4461.
2011-04	Targeting cathepsin S induces tumor cell autophagy via the EGFR-ERK signaling pathway	Cancer Research. 2011 Apr;71(Suppl. 8):Meeting Abstract 2864.
2011-03-07	Synthesis and biological evaluation of 4-aroyl-6,7,8-trimethoxyquinolines as a novel class of anticancer agents	Molecules. 2011 Mar 7;16(3):2274-2284.
2011-03-07	2-Amino-3,4,5-Trimethoxybenzophenones as Potent Tubulin Polymerization Inhibitors	ChemMedChem. 2011 Mar 7;6(3):450-456.
2011-01-26	Labdanecaryophyllic acid, a novel cytotoxic C35 terpenoid from Calocedrus macrolepis var. formosana	Tetrahedron Letters. 2011 Jan 26;52(4):515-517.
2011-01	BPR0C261 is a novel orally active antitumor agent with antimitotic and anti-angiogenic activities	Cancer Science. 2011 Jan;102(1):182-191.
2011-01	Investigations of survivin: the past, present and future	Frontiers in Bioscience. 2011 Jan;16:952-961.
2010-12-01	抗肿瘤化合物	ZL200580045509.7/2010-12-01
2010-12	Signal transducer and activator of transcription 3 activation up-regulates interleukin-6 autocrine production: a biochemical and genetic study of established cancer cell lines and clinical isolated human cancer cells	Molecular Cancer. 2010 Dec;9:Article number 309
2010-10	MBP-1 is efficiently encoded by an alternative transcript of the ENO1 gene but post-translationally regulated by proteasome-dependent protein turnover	FEBS Journal. 2010 Oct;277(20):4308-4231.
2010-10	Combined modalities of resistance in a cisplatin-driven human betel-associated oral squamous cell carcinoma	Annals of Oncology. 2010 Oct;21(Suppl. 8):52.
2010-09	Cancer cells acquire mitotic drug resistance properties through beta i-tubulin mutations and alterations in the expression of beta-tubulin isotypes	PLoS ONE. 2010 Sep;5(9):Article number e12564.
2010-08	Synthesis and biological evaluation of 7-arylindoline-1-benzenesulfonamides as a novel class of potent anticancer agents	MedChemComm. 2010 Aug;1(2):152-155.
2010-06-18	Cytotoxic C35 terpenoid cryptotrione from the bark of cryptomeria japonica	Organic Letters. 2010 Jun;12(12):2786-2789.
2010-06	Design and synthesis of alpha-ketoamides as cathepsin S inhibitors with potential applications against tumor invasion and angiogenesis	Journal of Medicinal Chemistry. 2010 Jun;53(11):4545-4549.
2010-06	Randomized, phase 1 study of everolimus in patients with advanced hepatocellular carcinoma	Annals of Oncology. 2010 Jun;21(Suppl. 6):27.
2010-05	Chamaecypanone C, a novel skeleton microtubule inhibitor, with anticancer activity by trigger caspase 8-Fas/FasL dependent apoptotic pathway in human cancer cells	Biochemical Pharmacology. 2010 May;79(9):1261-1271.
2010-05	Recent advances in anti-survivin treatments for cancer	Current Medicinal Chemistry. 2010 May;17(15):1509-1515.
2010-04-15	Targeting Hsp90 with small molecule inhibitors induces the over-expression of the anti-apoptotic molecule, survivin, in human A549, HONE-1 and HT-29 cancer cells	Molecular Cancer. 2010 Apr 15;9:Article number 77.
2010-04	Arecoline arrests cells at prometaphase by deregulating mitotic spindle assembly and spindle assembly checkpoint: Implication for carcinogenesis	Oral Oncology. 2010 Apr;46(4):255-262.
2010-03-11	5-Amino-2-Aroylquinolines as Highly Potent Tubulin Polymerization Inhibitors	Journal of Medicinal Chemistry. 2010 Mar 11;53(5):2309-2313.
2010-03	Paclitaxel and carboplatin-induced complete remission in peritoneal carcinomatosis of unknown origin: A report of two cases and review of the literature	Tumori. 2010 Mar-Apr;96(2):336-339.
2010-02	Antitumor activities and pharmacokinetics of silatecans DB-67 and DB-91	Pharmacological Research. 2010 Feb;61(2):108-115.
2009-12-15	Indole compounds	US7632955B2/2009-12-15

显示项目151-175 / 254. (共11页) << < 2 3 4 5 6 7 8 9 10 11 > >> 每页显示[10|25|50]项目